Загрузка...
Integration of Bioinformatics Resources Reveals the Therapeutic Benefits of Gemcitabine and Cell Cycle Intervention in SMAD4-Deleted Pancreatic Ductal Adenocarcinoma
Pancreatic ductal adenocarcinoma (PDAC) is the most common and aggressive type of pancreatic cancer. The five-year survival rate of PDAC is very low (less than 8%), which is associated with the late diagnosis, high metastatic potential, and resistance to therapeutic agents. The identification of bet...
Сохранить в:
| Опубликовано в: : | Genes (Basel) |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MDPI
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6827004/ https://ncbi.nlm.nih.gov/pubmed/31569425 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/genes10100766 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|